IP Library Granted Patent US 10,272,175
Granted Patent B2
US 10,272,175 · App. 15/033,752 · Granted Apr 30, 2019

Foams for oxygen delivery to wounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,175
App. No.
15/033,752
Granted
Apr 30, 2019
Kind
B2
Abstract

There is provided a composition comprising covalently linked segments of for example, polycaprolactone and polyethylene glycol that are linked by a cross-linker. Such a composition foams in the presence of a catalyst and a solution containing an oxygen forming chemical like hydrogen peroxide. The foamed composition retains oxygen for delivery to, for example, a wound, where it aids in healing.

Claims (5)

1. A foamable composition comprising a prepolymer comprising covalently linked segments of polycaprolactone and polyethylene glycol, a cross-linking agent connecting the polycaprolactone and the polyethylene glycol; a peroxide solution containing 20 wt. % peroxide; and a peroxide decomposition catalyst; wherein the cross-linking agent comprises an isocyanate prepolymer or a cross-linker with isocyanate content between 0.01 wt. % and 40 wt. % and an acid value between 0.01 mg and 100 mg of KOH/g of sample, wherein the cross-linking agent is present in an amount of between 1 wt. % and 3 wt. % based on the amount of prepolymer comprising covalently linked segments of polycaprolactone and polyethylene glycol, wherein the composition is capable of forming a foam that delivers 24.4 to 25.3 parts per million of oxygen within 24 hours.

2. The foamable composition of claim 1 , wherein the polycaprolactone is biodegradable with a weight loss of greater than 10 wt. % in 10 days, without the release of toxic products from the biodegradation.

3. The foamable composition of claim 1 , wherein a polymer matrix formed from the covalently linked segments of polycaprolactone and polyethylene glycol exhibits greater than or equal to 20 percent nominal hydration exposed to the peroxide solution.

4. The foamable composition of claim 1 , wherein the peroxide in the peroxide solution is hydrogen peroxide.

5. The foamable composition of claim 1 , wherein the peroxide decomposition catalyst is selected from the group consisting of sodium carbonate, magnesium carbonate, manganese and silver.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
SECURITY INTEREST Recorded Jan 23, 2019
From: COOLSYSTEMS, INC.; AVENT, INC.
To: CITIBANK, N.A.
Reel/Frame 048117/0410 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2017
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 042462/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2017
From: BATTELLE MEMORIAL INSTITUTE
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 042127/0267 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2017
From: CUEVAS, BRIAN J.; LAM, SOPHIE TRUC; BONN-SAVAGE, NATHAN G.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 042127/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2017
From: LALGUDI, RAMANATHAN S.; ROSHON, MELISSA S.; CAIN, ROBERT J.
To: BATTELLE MEMORIAL INSTITUTE
Reel/Frame 042321/0158 →